Mike Trujillo believed he had found a cure for his condition when he went for stem cell treatment. He couldn't have been more wrong.

Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026 ...

Veteran journalist Oren Nahari revealed he has ALS, a severe degenerative neurological disease. How many Israelis are ...

"Watching my mom die of ALS was one of the most awful things I’ve gone through. I don’t want my children to see me suffer like that." ...

Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing rinvatercept for ALS.

In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8® data submitted; Clene expects formal written meeting minutes early in the second quarter ...

Researchers at the University of Alabama at Birmingham are working to better understand ALS and find new ways to slow or stop the disease.

A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified ...

Experimental therapy RT1999 will soon be tested in the UK EXPERTS-ALS platform trial designed to rapidly screen potential ALS treatments.

To our knowledge, this analysis is the largest EHR-based study for identifying drug repurposing candidates for ALS. We identified several drugs that warrant further assessment as therapeutic options ...

Researchers are to test whether statins could help people with motor neurone disease (MND) live longer after data suggests cheap cholesterol-busting drug may 'prolong survival'. MND is a progressive ...